Although ALT, AST, CR, and CK displayed statistically significant differences between the APL and control groups (P < 0.05)(Table 1), their median values fell within the normal reference ranges, indicating no significant clinical implications. The gene discussed is GPT; the disease is acute promyelocytic leukemia.